Supernus Pharmaceuticals, Inc. (SUPN)
29.72
+0.52
(+1.78%)
USD |
NASDAQ |
Nov 13, 16:00
29.30
-0.42
(-1.41%)
After-Hours: 19:59
Supernus Pharmaceuticals Price : 29.72 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 29.41 | 29.92 | 28.81 | 29.72 | 2.072M |
| Nov 12, 2026 | 29.48 | 30.18 | 28.79 | 29.20 | 4.366M |
| Nov 11, 2026 | 28.75 | 29.66 | 28.67 | 29.45 | 3.073M |
| Nov 10, 2026 | 27.61 | 28.83 | 27.33 | 28.75 | 2.785M |
| Nov 09, 2026 | 27.04 | 27.91 | 26.11 | 27.62 | 4.203M |
| Nov 06, 2026 | 26.58 | 27.08 | 25.92 | 26.16 | 5.911M |
| Nov 05, 2026 | 28.29 | 28.79 | 26.52 | 26.74 | 6.080M |
| Nov 04, 2026 | 26.81 | 28.99 | 26.74 | 28.21 | 6.565M |
| Nov 03, 2026 | 28.35 | 31.62 | 27.97 | 28.15 | 9.053M |
| Nov 02, 2026 | 35.43 | 37.02 | 35.32 | 36.28 | 4.869M |
| Oct 30, 2026 | 42.07 | 43.72 | 39.53 | 41.92 | 2.819M |
| Oct 29, 2026 | 44.24 | 44.31 | 40.75 | 41.84 | 1.885M |
| Oct 28, 2026 | 40.46 | 41.18 | 39.67 | 41.08 | 1.099M |
| Oct 27, 2026 | 40.57 | 41.20 | 39.87 | 40.96 | 1.075M |
| Oct 26, 2026 | 40.72 | 40.87 | 39.58 | 40.77 | 930903.0 |
| Oct 23, 2026 | 41.68 | 41.95 | 39.96 | 40.70 | 1.159M |
| Oct 22, 2026 | 41.52 | 42.09 | 40.73 | 42.07 | 937420.0 |
| Oct 21, 2026 | 41.23 | 42.00 | 40.86 | 41.21 | 1.006M |
| Oct 20, 2026 | 39.95 | 41.74 | 39.77 | 41.23 | 1.240M |
| Oct 19, 2026 | 37.77 | 40.52 | 37.76 | 39.84 | 1.509M |
| Oct 16, 2026 | 39.49 | 39.50 | 37.54 | 37.88 | 1.442M |
| Oct 15, 2026 | 40.21 | 41.31 | 39.36 | 39.57 | 1.013M |
| Oct 14, 2026 | 41.93 | 43.26 | 39.97 | 40.18 | 906716.0 |
| Oct 13, 2026 | 42.94 | 43.29 | 41.71 | 42.01 | 1.197M |
| Oct 12, 2026 | 42.67 | 43.20 | 41.90 | 42.81 | 914563.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 71.44 |
| Prestige Consumer Healthcare, Inc. | 46.19 |
| Structure Therapeutics, Inc. | 20.00 |
| Corcept Therapeutics, Inc. | 72.94 |
| Veru, Inc. | 2.09 |
Price Related Metrics
| PS Ratio | 1.997 |
| PEG Ratio | -0.3121 |
| Price to Book Value | 1.630 |
| Price to Free Cash Flow | 19.87 |
| Earnings Yield | -2.57% |
| Market Cap | 1.731B |
| PEGY Ratio | -0.2559 |
| Operating PE Ratio | 129.35 |